The vaccine, which was developed by the US National Institutes of Health, has safely been tested on animals and is the first vaccine to undergo human trials in Africa since the latest Ebola outbreak.
An Ebola vaccine trial has began in West Africa’s Mali, according to a report published by NBC News.
The vaccine, which was developed by the US National Institutes of Health, has safely been tested on animals and is the first vaccine to undergo human trials in Africa since the latest Ebola outbreak.
Only three health care workers have been administered with the experimental vaccine as part of the Mali clinical trial, as the safety of the vaccine on humans is yet to be determined.
Samba Sow, Director General of Mali’s Center for Vaccine Development, has stated that the trial is only in the early stages.
“However, if it is eventually shown to work and if this information can be generated fast enough, it could become a public health tool to bring the current, and future, Ebola virus disease epidemics under control,” Sow added.
The current Ebola outbreak has led to the infection of more than 8000 people and 3000 deaths, mostly in West Africa.